Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Relay Therapeutics, Inc. | RLAY | 450K | $8.42M |
Revolution Medicines, Inc. | RVMD | 500K | $93.64M |
Abivax S.A. | ABVX | 605K | $80.62M |
Amylyx Pharmaceuticals, Inc. | AMLX | 800K | $14.37M |
Relmada Therapeutics, Inc. | RLMD | 842.11K | $5.83M |
Definium Therapeutics, Inc. | DFTX | 998.5K | $46.97M |
Corvus Pharmaceuticals, Inc. | CRVS | 1.1M | $16.43M |
Ocular Therapeutix, Inc. | OCUL | 1.3M | $12.77M |
Kodiak Sciences Inc. | KOD | 1.48M | $57.57M |
Allogene Therapeutics, Inc. | ALLO | 1.5M | $3.12M |
uniQure N.V. | QURE | 1.5M | $69.24M |
Vir Biotechnology, Inc. | VIR | 1.87M | $19.01M |
Inovio Pharmaceuticals, Inc. | INO | 2.84M | $3.13M |
Replimune Group, Inc. | REPL | 3.98M | $44.09M |
Precigen, Inc. | PGEN | 5.15M | $29.36M |
Tango Therapeutics, Inc. | TNGX | 10.88M | $339.99M |